Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Riluzole is a medication used to treat amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Riluzole delays the onset of ventilator-dependence or tracheostomy in some people and may increase survival by two to three months. Riluzole is available in tablet and liquid form. A thin film version of riluzole which dissolves on the tongue…
Applications & Research
Explore the main themes, entities and connections around Riluzole. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
glutamate also may known effects treatment disease als states available action amyotrophic lateral sclerosis binding exservan legal status cyp1a2 approved
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Riluzole | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Riluzole | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Riluzole | ATC code | N07XX02 (WHO) | 1.00 | infobox |
| Riluzole | Bioavailability | 60±18% | 1.00 | infobox |
| Riluzole | CAS Number | 1744-22-5 Y | 1.00 | infobox |
| Riluzole | ChEMBL | ChEMBL744 Y | 1.00 | infobox |
| Riluzole | ChemSpider | 4892 Y | 1.00 | infobox |
| Riluzole | CompTox Dashboard (EPA) | DTXSID3045192 | 1.00 | infobox |
| Riluzole | DrugBank | DB00740 Y | 1.00 | infobox |
| Riluzole | ECHA InfoCard | 100.124.754 | 1.00 | infobox |
| Riluzole | Elimination half-life | 9–15 hours | 1.00 | infobox |
| Riluzole | Excretion | Urine (90%) | 1.00 | infobox |
| Riluzole | Formula | C8H5F3N2OS | 1.00 | infobox |
| Riluzole | IUPHAR/BPS | 2326 | 1.00 | infobox |
| Riluzole | KEGG | D00775 Y | 1.00 | infobox |
| Riluzole | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Riluzole | Legal status | CA: ℞-only | 1.00 | infobox |
| Riluzole | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Riluzole | Legal status | US: ℞-only | 1.00 | infobox |
| Riluzole | Legal status | EU: Rx Only | 1.00 | infobox |
| Riluzole | MedlinePlus | a696013 | 1.00 | infobox |
| Riluzole | Metabolism | Hepatic (CYP1A2) | 1.00 | infobox |
| Riluzole | Molar mass | 234.20 g·mol−1 | 1.00 | infobox |
| Riluzole | Pregnancy category | AU: B3 | 1.00 | infobox |
| Riluzole | Protein binding | 97% | 1.00 | infobox |
| Riluzole | PubChem CID | 5070 | 1.00 | infobox |
| Riluzole | Routes of administration | By mouth | 1.00 | infobox |
| Riluzole | Trade names | Rilutek, Tiglutik, Exservan, others | 1.00 | infobox |
| Riluzole | UNII | 7LJ087RS6F | 1.00 | infobox |
| Riluzole | is a | medication used to treat amyotrophic lateral sclerosis | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.